Cryo-Cell International Accounts Payable

As of the most recent data (August 2026), CCEL shows a accounts payable of $2.4M. That compares with $2.6M in the prior-year period — down 7.3% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, CCEL's accounts payable is now $2.4M (was $2.6M) — a 7.3% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Cryo-Cell International is outperforming or lagging.

Tracking CCEL's accounts payable over time shows whether Cryo-Cell International is scaling, shrinking, or reshaping that part of the business. The current reading is $2.4M That compares with $2.6M in the prior-year period — down 7.3% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this accounts payable page, Stockcircle has Cryo-Cell International's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect accounts payable (currently $2.4M) with ownership activity and broader fundamentals.

Cryo-Cell International's accounts payable is $2.4M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.